Literature DB >> 13517120

[A new method of treating interstitial plasma cell pneumonia in premature infant with 5-valent antimony & aromatic diamidines].

G IVADY, L PALDY.   

Abstract

Entities:  

Keywords:  AMIDINES/therapeutic use; ANTIMONY/therapeutic use; INFANT, PREMATURE/diseases; PNEUMONIA, INTERSTITIAL PLASMA CELL/therapy

Mesh：

Substances：

Year:  1958        PMID： 13517120

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd


× No keyword cloud information.
  16 in total

1.  PNEUMOCYSTIS CARINII PNEUMONIA AND CONGENITAL HYPOGAMMAGLOBULINAEMIA.

Authors:  W C MARSHALL; H J WESTON; M BODIAN
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

2.  Pneumocystis pneumonia associated with agammaglobulinaemia.

Authors:  J G RUSSELL
Journal:  Arch Dis Child       Date:  1959-08       Impact factor: 3.791

Review 3.  AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome.

Authors:  D M Mitchell; M A Johnson
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

4.  In vitro inhibition of platelet function and coagulation by pentamidine isethionate.

Authors:  S J Kempin; C W Jackson; C C Edwards
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

5.  Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host.

Authors:  F W Ryning; J Mills
Journal:  West J Med       Date:  1979-01

Review 6.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

7.  Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.

Authors:  R M Kluge; D M Spaulding; A J Spain
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia.

Authors:  R R Tidwell; S K Jones; N A Naiman; L C Berger; W B Brake; C C Dykstra; J E Hall
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 9.  Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia.

Authors:  K L Goa; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

10.  Metabolic N-hydroxylation of pentamidine in vitro.

Authors:  B J Berger; R J Lombardy; G D Marbury; C A Bell; C C Dykstra; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.